EOLS Evolus, Inc. Stock Quote

EOLS [NASD]

Healthcare | Drug Manufacturers - Specialty & Generic | USA

Index	-	P/E	-	EPS (ttm)	-1.41	Insider Own	15.10%	Shs Outstand	56.08M	Perf Week	-0.49%
Market Cap	577.22M	Forward P/E	-	EPS next Y	-0.17	Insider Trans	-2.30%	Shs Float	37.33M	Perf Month	5.26%
Income	-78.60M	PEG	-	EPS next Q	-0.27	Inst Own	48.90%	Short Float	5.73%	Perf Quarter	-19.87%
Sales	132.40M	P/S	4.36	EPS this Y	80.50%	Inst Trans	5.93%	Short Ratio	4.10	Perf Half Y	5.81%
Book/sh	0.84	P/B	12.14	EPS next Y	82.10%	ROA	-34.80%	Target Price	16.38	Perf Year	7.71%
Cash/sh	-	P/C	-	EPS next 5Y	16.50%	ROE	-107.10%	52W Range	5.06 - 14.34	Perf YTD	56.68%
Dividend	-	P/FCF	-	EPS past 5Y	-2.00%	ROI	-29.70%	52W High	-29.22%	Beta	2.00
Dividend %	-	Quick Ratio	2.40	Sales past 5Y	-	Gross Margin	57.40%	52W Low	100.55%	ATR	0.71
Employees	174	Current Ratio	2.60	Sales Q/Q	42.50%	Oper. Margin	-55.80%	RSI (14)	49.91	Volatility	8.76% 5.69%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	-37.20%	Profit Margin	-59.30%	Rel Volume	2.46	Prev Close	10.20
Shortable	Yes	LT Debt/Eq	1.52	Earnings	Aug 02 BMO	Payout	-	Avg Volume	521.79K	Price	10.15
Recom	1.90	SMA20	3.62%	SMA50	-8.84%	SMA200	3.73%	Volume	214,074	Change	-0.49%

Jun-23-22

Initiated

Needham

Buy

$18

May-12-22

Upgrade

Barclays

Underweight → Equal Weight

$8 → $10

Jan-20-22

Upgrade

Truist

Hold → Buy

$11

May-06-21

Upgrade

Mizuho

Neutral → Buy

$15

Apr-08-21

Reiterated

H.C. Wainwright

Buy

$20 → $22

Feb-24-21

Downgrade

Truist

Buy → Hold

$12

Jul-07-20

Downgrade

Mizuho

Buy → Neutral

$8 → $3

Feb-06-20

Resumed

Mizuho

Buy

Nov-26-19

Initiated

SVB Leerink

Outperform

$25

Sep-05-19

Resumed

Mizuho

Buy

$30

Jun-28-19

Initiated

Wells Fargo

Market Perform

$16

Jun-11-19

Initiated

Barclays

Underweight

$13

Mar-20-19

Initiated

SunTrust

Buy

$30

Feb-14-19

Initiated

H.C. Wainwright

Buy

$37

Jan-29-19

Initiated

Stifel

Buy

$27

Sep-06-22 04:05PM	Evolus Announces Inducement Grants for New Chief Financial Officer Business Wire
Aug-30-22 08:15AM	Evolus Appoints Sandra Beaver as Chief Financial Officer Business Wire
Aug-29-22 05:45AM	Evolus to Participate in the H.C. Wainwright 24th Annual Global Investment Conference Business Wire
Aug-24-22 08:14AM	Newly Published Post Hoc Analysis Evaluates Efficacy of Jeuveau® in Adult Males Compared to BOTOX® Business Wire
Aug-22-22 08:37AM	Owning 42% shares,institutional owners seem interested in Evolus, Inc. (NASDAQ:EOLS), Simply Wall St.
Aug-02-22 09:25AM	Evolus, Inc. (EOLS) Reports Q2 Loss, Tops Revenue Estimates Zacks -17.62%
08:05AM	Evolus Reports Second Quarter 2022 Results and Provides Business Update Business Wire
Jul-19-22 08:45AM	Evolus to Report Second Quarter 2022 Results and Provide Business Update Business Wire
08:37AM	Evolus Launches New Campaign Inspiring Consumers to "Switch Your Tox and Love Evolus Forever" Business Wire
Jul-12-22 08:47AM	Evolus Successfully Completes Patient Enrollment in Phase II Clinical Study Evaluating "Extra-Strength" Dose of Jeuveau® Business Wire
Jun-24-22 01:35PM	Needham Is Bullish On This Botox Equivalent Aesthetics Company Benzinga +5.10%
11:29AM	Investors in Evolus (NASDAQ:EOLS) have unfortunately lost 15% over the last three years Simply Wall St.
Jun-08-22 09:55AM	Does Evolus, Inc. (EOLS) Have the Potential to Rally 28% as Wall Street Analysts Expect? Zacks
09:40AM	Is Computer Programs and Systems (CPSI) Stock Outpacing Its Medical Peers This Year? Zacks
Jun-02-22 08:54AM	Peer-Reviewed Post Hoc Analysis Shows Jeuveau® is Highly Effective for Millennials by All Measures and at All Time Points Assessed Business Wire
May-23-22 09:55AM	Wall Street Analysts Predict a 34% Upside in Evolus, Inc. (EOLS): Here's What You Should Know Zacks
09:40AM	Has Evolus (EOLS) Outpaced Other Medical Stocks This Year? Zacks
May-18-22 08:15AM	Evolus Celebrates Third Anniversary of the Launch of Jeuveau® in the United States Business Wire -11.55%
May-11-22 08:45AM	Evolus to Participate in the H.C. Wainwright Global Investment Conference Business Wire +7.72%
May-10-22 06:15PM	Evolus, Inc. (EOLS) Reports Q1 Loss, Tops Revenue Estimates Zacks
04:05PM	Evolus Reports First Quarter 2022 Results and Provides Business Update Business Wire
11:26AM	Is Evolus (NASDAQ:EOLS) Using Too Much Debt? Simply Wall St.
Apr-26-22 08:45AM	Evolus to Report First Quarter 2022 Results and Provide Business Update Business Wire
Apr-11-22 07:56AM	Top 9 Stocks Billionaire Larry Robbins Just Added to His Portfolio Insider Monkey
Mar-31-22 08:15AM	Evolus Announces First Patient Enrolled in Phase II Clinical Study Evaluating "Extra-Strength" Dose of Jeuveau® Business Wire
Mar-15-22 12:44PM	What Kind Of Shareholders Own Evolus, Inc. (NASDAQ:EOLS)? Simply Wall St.
Mar-08-22 08:45AM	Evolus to Participate in the Barclays Global Healthcare Conference Business Wire
Mar-03-22 05:55PM	Evolus, Inc. (EOLS) Reports Q4 Loss, Misses Revenue Estimates Zacks
04:05PM	Evolus Reports Fourth Quarter and Full-Year 2021 Results and Provides Business Update Business Wire
04:05PM	Evolus Announces Retirement of Chief Financial Officer Lauren Silvernail Business Wire
Mar-01-22 08:45AM	Evolus Names Christos Monovoukas Senior Vice President of Corporate Development Business Wire
Feb-28-22 06:15PM	BioLife Solutions, Inc. (BLFS) Reports Q4 Loss, Tops Revenue Estimates Zacks
02:27AM	Strength Seen in PetIQ (PETQ): Can Its 7.1% Jump Turn into More Strength? Zacks
Feb-24-22 03:00PM	Will Evolus, Inc. (EOLS) Report Negative Earnings Next Week? What You Should Know Zacks +7.90%
Feb-17-22 08:45AM	Evolus to Report Fourth Quarter and Year End 2021 Results and Provide Business Update Business Wire
Feb-08-22 08:45AM	Evolus Receives Acceptance of Submission in Australia, a Pivotal Step in Approval Process for Nuceiva® Business Wire +7.06%
Feb-02-22 09:15AM	Evolus to Participate in the Virtual 11th Annual SVB Leerink Global Healthcare Conference Business Wire
Jan-26-22 08:45AM	Evolus Announces Preliminary Unaudited Fourth Quarter and Full-Year 2021 Net Revenue and Provides 2022 Guidance Business Wire +17.26%
Jan-18-22 01:38PM	HealthInvest Partners AB Buys McKesson Corp, Cardinal Health Inc, AmerisourceBergen Corp, Sells ... GuruFocus.com -9.22%
Jan-12-22 07:09PM	Top Pharmaceutical Stocks for Q1 2022 Investopedia
Jan-05-22 08:45AM	Evolus Expands Board of Directors With Appointment of Digital and Beauty Innovator Brady Stewart Business Wire
Dec-20-21 08:45AM	Evolus Joins Nasdaq Biotechnology Index Business Wire
Dec-14-21 08:45AM	Evolus Enters Into $125 Million Credit Facility with Pharmakon Advisors Business Wire
Nov-09-21 08:30AM	Evolus Announces Participation in November Investment Conferences GlobeNewswire
Nov-07-21 07:55AM	Is Evolus (NASDAQ:EOLS) A Risky Investment? Simply Wall St.
Nov-02-21 09:35AM	Evolus, Inc. (EOLS) Reports Q3 Loss, Lags Revenue Estimates Zacks
08:03AM	Evolus Reports Third Quarter 2021 Results and Provides Business Update GlobeNewswire
08:01AM	Evolus Initiates Phase II Program with Extra Strength Dose for Extended Duration GlobeNewswire
Nov-01-21 04:10PM	Evolus Announces Appointment of Jessica Novak as Senior Vice President, Human Resources GlobeNewswire +7.16%
Oct-26-21 03:02PM	Evolus, Inc. (EOLS) Expected to Beat Earnings Estimates: Should You Buy? Zacks
Oct-22-21 09:00AM	Evolus to Report Third Quarter 2021 Results and Provide Business Update GlobeNewswire
Sep-23-21 08:58AM	What Kind Of Shareholders Own Evolus, Inc. (NASDAQ:EOLS)? Simply Wall St.
Sep-02-21 09:00AM	Evolus Announces Participation in September Investment Conferences GlobeNewswire
Aug-26-21 08:11AM	4 Stocks Insiders Are Buying Benzinga
Aug-18-21 08:52AM	4 Stocks Insiders Are Buying Benzinga
Aug-09-21 02:53AM	When Will Evolus, Inc. (NASDAQ:EOLS) Become Profitable? Simply Wall St.
Aug-04-21 06:05PM	Evolus, Inc. (EOLS) Reports Q2 Loss, Tops Revenue Estimates Zacks
04:05PM	Evolus Reports Second Quarter 2021 Results and Provides Business Update GlobeNewswire
Jul-28-21 03:04PM	Will Evolus, Inc. (EOLS) Report Negative Earnings Next Week? What You Should Know Zacks
Jul-22-21 09:00AM	Evolus to Report Second Quarter 2021 Results and Provide Business Update GlobeNewswire
Jul-03-21 06:25AM	Can Evolus Disrupt the Botox Market? Motley Fool
Jun-30-21 09:00AM	Evolus Announces Appointment of David K. Erickson as Vice President, Investor Relations GlobeNewswire
Jun-25-21 04:51AM	Did Business Growth Power Evolus' (NASDAQ:EOLS) Share Price Gain of 149%? Simply Wall St.
Jun-24-21 09:00AM	Peer Reviewed Article Highlights Efficacy and Safety of Jeuveau® in Patients with Skin of Color GlobeNewswire
May-19-21 09:00AM	Evolus Appoints Dan Stewart as Vice President and General Manager, International GlobeNewswire
May-12-21 04:05PM	Evolus Reports First Quarter 2021 Results and Provides Business Update GlobeNewswire
02:30PM	Evolus, Inc. to Host Earnings Call ACCESSWIRE
10:33AM	Repeat Doses Of Evolus' Frown Lines Treatment Are Safe, With Decreasing Rates Of Adverse Events Benzinga
09:00AM	Aesthetic Surgery Journal Publishes Long Term Safety and Efficacy Data of Jeuveau® for the Treatment of Moderate to Severe Frown Lines GlobeNewswire
May-11-21 12:18PM	Aurora Cannabis (ACB) to Post Q3 Earnings: What's in Store? Zacks
May-10-21 08:24AM	Why Evolus (EOLS) Might Surprise This Earnings Season Zacks
May-04-21 04:05PM	Evolus to Report First Quarter 2021 Results and Provide Business Update GlobeNewswire
May-03-21 03:01PM	Evolus, Inc. (EOLS) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release Zacks
Apr-29-21 04:05PM	Evolus to Participate in the 7th Annual Truist Securities Life Sciences Summit GlobeNewswire
Apr-22-21 06:02PM	Why Evolus Stock Dived by Almost 19% Today Motley Fool -18.86%
Apr-21-21 10:30PM	Evolus Announces Pricing of Public Offering of Common Stock GlobeNewswire +11.09%
04:01PM	Evolus Announces Proposed Public Offering of Common Stock GlobeNewswire
Mar-25-21 02:45AM	Evolus Slips 10% On Wider-Than-Expected 4Q Loss SmarterAnalyst -23.14%
Mar-24-21 05:35PM	Evolus, Inc. (EOLS) Reports Q4 Loss, Lags Revenue Estimates Zacks
04:05PM	Evolus Reports Fourth Quarter and Full Year 2020 Results and Provides Business Update GlobeNewswire
Mar-23-21 01:52PM	Daewoong Pharmaceutical Injects More Liquidity In Evolus Benzinga +11.97%
09:21AM	Evolus to Report Fourth Quarter and Year End 2020 Results and Provide Business Update GlobeNewswire
09:17AM	Evolus Strengthens Balance Sheet Through a $25.5 Million Cash Infusion and Elimination of $127.4 Million of Debt and Milestone Payments GlobeNewswire
Mar-02-21 04:05PM	Evolus to Participate in Two Upcoming Investor Conferences GlobeNewswire +12.07%
Mar-01-21 09:41AM	Is a Surprise Coming for Evolus (EOLS) This Earnings Season? Zacks
Feb-26-21 09:00AM	Evolus Announces Promotion of Crystal Muilenburg to Chief Marketing Officer GlobeNewswire +5.30%
Feb-23-21 09:00AM	Evolus Announces Preliminary, Unaudited, Fourth Quarter and Full Year 2020 Net Revenue GlobeNewswire -10.28%
Feb-19-21 04:05PM	EOLS Stock: The Big News That Has Evolus Shares Skyrocketing Today InvestorPlace +71.65%
04:05PM	Evolus to Participate in the 10th Annual SVB Leerink Global Healthcare Conference GlobeNewswire
10:42AM	Evolus Shares Surge After Settling Jeuveau Related Litigation With AbbVie, Medytox Benzinga
09:15AM	AbbVie, Evolus, and Medytox Announce Resolution of Intellectual Property Litigation PR Newswire
Feb-17-21 02:15AM	When Can We Expect A Profit From Evolus, Inc. (NASDAQ:EOLS)? Simply Wall St.
Jan-28-21 08:44AM	Do Options Traders Know Something About Evolus (EOLS) Stock We Don't? Zacks
Dec-19-20 01:04AM	Analysts Have Just Cut Their Evolus, Inc. (NASDAQ:EOLS) Revenue Estimates By 23% Simply Wall St.
Dec-17-20 08:10AM	The Daily Biotech Pulse: MacroGenics Breast Cancer Drug Wins FDA Approval, Adcom Test Awaits Moderna, Virios To Make Wall Street Debut Benzinga +21.53%
Dec-16-20 05:45PM	Evolus Provides Update on United States International Trade Commission (ITC) Case GlobeNewswire -8.93%
Dec-15-20 03:00PM	EOLS Final Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Evolus, Inc. Shareholders of Class Action and Lead Plaintiff Deadline: December 15, 2020 ACCESSWIRE
10:00AM	EOLS Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Evolus, Inc. Shareholders of Class Action and Lead Plaintiff Deadline: December 15, 2020 Newsfile
09:27AM	EOLS FINAL DEADLINE TODAY: ROSEN, NATIONAL TRIAL LAWYERS, Reminds Evolus, Inc. Investors of Important December 15 Deadline in Securities Class Action EOLS GlobeNewswire
Dec-14-20 08:23PM	Evolus Deadline Alert Newsfile

Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorporated in 2012 and is headquartered in Newport Beach, California.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
FARRELL PETER C	Director	Sep 06	Buy	9.10	10,000	91,048	10,000	Sep 06 08:03 PM
BLANK SIMONE	Director	Sep 06	Buy	9.24	20,000	184,844	54,881	Sep 08 09:29 AM
Medytox Inc.	10% Owner	Aug 01	Sale	13.28	26,000	345,361	7,437,652	Aug 03 04:08 PM
SILVERNAIL LAUREN P	See Remarks	May 18	Sale	12.42	52,015	646,026	141,571	May 18 08:21 PM
SILVERNAIL LAUREN P	See Remarks	May 17	Sale	13.92	16,189	225,354	193,586	May 18 08:21 PM
MOATAZEDI DAVID	See Remarks	May 16	Sale	13.64	55,321	754,307	491,961	May 18 08:21 PM
GILL DAVID N	Director	May 16	Sale	13.62	5,000	68,080	29,568	May 17 06:49 PM
GILL DAVID N	Director	May 13	Sale	13.10	5,313	69,584	34,568	May 17 06:49 PM
MOATAZEDI DAVID	See Remarks	Mar 28	Sale	11.62	6,104	70,928	547,282	Mar 30 07:02 PM
Avelar Rui	See Remarks	Mar 08	Sale	9.73	10,192	99,121	253,189	Mar 10 07:23 PM
MOATAZEDI DAVID	See Remarks	Mar 08	Sale	9.73	37,972	369,293	553,386	Mar 10 07:24 PM
Muilenburg Crystal	Chief Marketing Officer	Mar 08	Sale	9.73	6,495	63,166	134,248	Mar 10 07:24 PM
SILVERNAIL LAUREN P	See Remarks	Mar 08	Sale	9.73	10,192	99,121	209,775	Mar 10 07:23 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience